ArticleFrontiers in oncology2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the
Paola Verachi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Paola Verachi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.